TrialRheumatology international2022
Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial.
Pooja J Belani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it